IP Library Granted Patent US 8,257,933
Granted Patent B2
US 8,257,933 · App. 12/227,244 · Granted Sep 4, 2012

Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease

Assignees: Keio University; Oriental Yeast Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,257,933
App. No.
12/227,244
Granted
Sep 4, 2012
Kind
B2
Abstract

A novel method for detection of an inflammatory disease and a novel composition for prevention or treatment of an inflammatory disease are provided. The method for detection of an inflammatory disease comprises using RANKL and/or OPG as a marker in a biological sample. The composition for prevention or treatment of an inflammatory disease comprises RANKL and/or M-CSF as an active ingredient.

Claims (10)

1. A method for detection of a bacterial infectious disease or sepsis with use of RANKL as a marker in a biological blood sample, the method comprising:

(i) measuring by immunoassay a concentration of soluble RANKL in the biological blood sample isolated from a subject; and

(ii) determining that the subject is affected with the bacterial infectious disease or sepsis when the concentration of the soluble RANKL in the biological blood sample is lower than that of a normal subject,

wherein the bacterial infectious disease is a salmonella infectious disease, and

the sepsis is lipopolysaccharide or (LPS)-induced sepsis.

2. The method for detection of a bacterial infectious disease or sepsis according to claim 1 , wherein the method uses OPG in addition to RANKL as a marker in the biological blood sample, and the method comprises:

(i) measuring by immunoassay a concentration of OPG in the biological blood sample isolated from the subject in addition to the concentration of soluble RANKL; and

(ii) determining that the subject is affected with bacterial infectious disease or sepsis when a ratio of the concentration of the soluble RANKL relative to the concentration of the OPG in the biological blood sample is lower than the ratio of a normal subject.

3. The method for detection of a bacterial infectious disease or sepsis according to claim 2 , the method comprising a step of isolating the blood sample from the subject.

4. The method for detection of a bacterial infectious disease or sepsis according to claim 1 , the method comprising a step of isolating the blood sample from the subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2008
From: MARUYAMA, KENTA; MATSUO, KOICHI; YASUDA, HISATAKA
To: KEIO UNIVERSITY; ORIENTAL YEAST CO., LTD.
Reel/Frame 021867/0811 →
Continuity (1)
Related Publication 20090202469A1 · Aug 13, 2009